Tesamorelin Peptide Structure: How It Differs From Natural GHRH
Tesamorelin peptide is a lab-made version of growth hormone-releasing hormone, or GHRH, a natural peptide made in the hypothalamus. Like the other compounds covered in our introduction to peptide research, it is a short chain of amino acids that cells read as a signal. It keeps the same 44 amino acids as the natural hormone and adds one small chemical tag to the very first one. That tag is why researchers so often compare tesamorelin with natural GHRH, so this guide starts with how the natural version works and why its first few amino acids matter.
What Is Tesamorelin Peptide?
Tesamorelin has the same 44-amino-acid chain as human GHRH. The only difference is a short six-carbon chain, called a hexenoyl group, attached to the first amino acid (tyrosine). That small addition makes tesamorelin slightly heavier than the natural hormone, at about 5,136 daltons compared with about 5,040. In cell-based tests, tesamorelin attaches to GHRH receptors and switches them on with a strength similar to the natural hormone.
How Does Natural GHRH Work?
Natural GHRH attaches to a receptor on cells in the pituitary gland, a small gland at the base of the brain. The receptor then starts a chain of signals inside the cell, and the end result is more growth hormone being made. A 2020 study used a technique called cryo-electron microscopy to picture the receptor holding GHRH (the structure is public as PDB entry 7CZ5). The image shows GHRH as a spiral, with its first few amino acids making many of the contacts with the receptor.
Why Is the Start of the GHRH Chain So Fragile?
In human blood plasma tested in the lab, natural GHRH gets trimmed quickly. An enzyme called DPP-IV snips the first two amino acids off the front, and the shorter fragment that is left has less than one-thousandth of the original activity. A second enzyme of the trypsin type makes a smaller cut further along the chain. In that same test, intact GHRH had a half-life of about 17 minutes.
The 1989 study in the Journal of Clinical Investigation also showed that swapping either of the first two amino acids for a D-amino acid, which is a mirror-image version, stops DPP-IV from cutting.
What Does the Extra Chain Change?
The hexenoyl group sits at the exact end of the molecule where DPP-IV does its cutting. Tesamorelin is described as more resistant to DPP-IV than natural GHRH, which fits the earlier finding that changes at the front of the chain block the enzyme. That does not make it immune to every enzyme, and the work cited here does not rule out the other cutting points. Anyone comparing the two in plasma or cell tests needs to keep that in mind, and to confirm exactly what is in the vial. Batch analysis such as the reports on our lab reports page shows the identity and purity checks behind a given lot.
How Is Tesamorelin Different From Sermorelin?
The two names are often mixed up, but they are different molecules. Sermorelin is only the first 29 amino acids of GHRH and carries no tag at the front. Tesamorelin keeps all 44 and has the hexenoyl tag. Modified GRF(1-29) is a third GHRH-based peptide, which is 29 amino acids long and has four amino acids swapped. It sits alongside other growth hormone-related compounds in our peptides collection.
Important: This article is for scientific information only. The peptides discussed are intended exclusively for scientific and laboratory research and are not intended for human or veterinary consumption, administration, diagnosis, treatment or therapeutic use.